- Symbol
- CDXS
- Segment MIC
- XNGS
- ISIN
- US1920051067
- Trading currency
- USD
XNGS:CDXS — listed on NASDAQ GLOBAL SELECT MARKET
Codexis Inc. operates in the biopharmaceutical sector, focusing on enzyme engineering for therapeutic applications. The company provides solutions for RNA manufacturing, pharmaceutical biocatalysis, and molecular biology and diagnostic applications. Its proprietary platforms, including the CodeEvolver® Technology Platform and ECO Synthesis® Manufacturing Platform, enable the development of efficient and sustainable processes for drug manufacturing. Codexis serves customers in the pharmaceutical industry, offering products that enhance quality and yield while reducing environmental impact.